Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »

For full access to this article login to GEN Select now.

Mar 3, 2014

The Top 25 Best-Selling Drugs of 2013

Find out how many billions these blockbusters raked in.

The Top 25 Best-Selling Drugs of 2013

These therapeutics didn’t bring in less than $3 billion last year. [© grandeduc - Fotolia.com]

  • #14. Neulasta (pegfilgrastim)

    Sponsor(s): Amgen2

    Indication(s): Neutropenia caused by cancer chemotherapy

    2013 sales: $4.392 billion

    2012 sales: $4.092 billion

    % Change: 7.3%

    Q4 2013 sales: $1.098 ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »